ADAMAS PHARMACEUTICALS INC's ticker is and the CUSIP is 00548A906. A total of 2 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $179,000 | -12.7% | 32,200 | -17.4% | 0.00% | – |
| Q2 2021 | $205,000 | +388.1% | 39,000 | +44218.2% | 0.00% | – |
| Q1 2021 | $42,000 | +740.0% | 88 | +633.3% | 0.00% | – |
| Q4 2020 | $5,000 | +150.0% | 12 | +140.0% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 5 | -54.5% | 0.00% | – |
| Q1 2020 | $3,000 | -80.0% | 11 | -72.5% | 0.00% | – |
| Q4 2019 | $15,000 | -61.5% | 40 | -48.1% | 0.00% | – |
| Q3 2019 | $39,000 | +1850.0% | 77 | +1825.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 4 | +100.0% | 0.00% | – |
| Q1 2019 | $1,000 | -99.6% | 2 | -99.2% | 0.00% | -100.0% |
| Q4 2018 | $225,000 | -59.7% | 264 | -5.4% | 0.00% | -50.0% |
| Q3 2018 | $558,000 | -26.2% | 279 | -4.8% | 0.00% | -33.3% |
| Q2 2018 | $756,000 | +2338.7% | 293 | -6.4% | 0.00% | +200.0% |
| Q1 2018 | $31,000 | -63.5% | 313 | +131.9% | 0.00% | -75.0% |
| Q4 2017 | $85,000 | – | 135 | +6650.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 2 | -92.0% | 0.00% | -100.0% |
| Q4 2015 | $35,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 553 | $61,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 49,400 | $261,000 | 0.00% |
| SIMPLEX TRADING, LLC | 39,000 | $205,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |